Company Filing History:
Years Active: 2007-2015
Title: The Innovations of Dong Cheng
Introduction
Dong Cheng is a prominent inventor based in Furlong, PA (US). He has made significant contributions to the field of medicinal chemistry, holding a total of 7 patents. His work primarily focuses on developing novel compounds that have therapeutic applications.
Latest Patents
One of his latest patents is related to Aryl dihydropyridinones and piperidinone MGAT2 inhibitors. This invention provides compounds of Formula (I) or a stereoisomer, or a pharmaceutically acceptable salt thereof, which are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors that may be used as medicaments. Another significant patent involves the Adiponectin receptor variant, AdipoR2v2. This invention provides novel polynucleotides encoding various polypeptides related to human and mouse AdipoR receptors. It also includes vectors, host cells, antibodies, and methods for producing these polypeptides, which can be applied in diagnostic and therapeutic methods for various diseases.
Career Highlights
Dong Cheng is currently employed at Bristol-Myers Squibb Company, where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the understanding of metabolic diseases and their treatment.
Collaborations
He has collaborated with notable coworkers such as Ning Lee and John N Feder, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dong Cheng's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the development of new therapeutic agents.